» Articles » PMID: 39065111

A Critical Analysis of All-Cause Deaths During COVID-19 Vaccination in an Italian Province

Overview
Journal Microorganisms
Specialty Microbiology
Date 2024 Jul 27
PMID 39065111
Authors
Affiliations
Soon will be listed here.
Abstract

Immortal time bias (ITB) is common in cohort studies and distorts the association estimates between the treated and untreated. We used data from an Italian study on COVID-19 vaccine effectiveness, with a large cohort, long follow-up, and adjustment for confounding factors, affected by ITB, with the aim to verify the real impact of the vaccination campaign by comparing the risk of all-cause death between the vaccinated population and the unvaccinated population. We aligned all subjects on a single index date and considered the "all-cause deaths" outcome to compare the survival distributions of the unvaccinated group versus various vaccination statuses. The all-cause-death hazard ratios in univariate analysis for vaccinated people with 1, 2, and 3/4 doses versus unvaccinated people were 0.88, 1.23, and 1.21, respectively. The multivariate values were 2.40, 1.98, and 0.99. Possible explanations of this trend of the hazard ratios as vaccinations increase could be a harvesting effect; a calendar-time bias, accounting for seasonality and pandemic waves; a case-counting window bias; a healthy-vaccinee bias; or some combination of these factors. With 2 and even with 3/4 doses, the calculated Restricted Mean Survival Time and Restricted Mean Time Lost have shown a small but significant downside for the vaccinated populations.

Citing Articles

Risk stratification for future cardiac arrest after COVID-19 vaccination.

McCullough P, Hulscher N World J Cardiol. 2025; 17(2):103909.

PMID: 40061285 PMC: 11886387. DOI: 10.4330/wjc.v17.i2.103909.


All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data.

Alessandria M, Malatesta G, Di Palmo G, Cosentino M, Donzelli A F1000Res. 2025; 13:886.

PMID: 40028449 PMC: 11868741. DOI: 10.12688/f1000research.154058.2.


The WHO Algorithm for Causality Assessment of Adverse Effects Following Immunization with Genetic-Based Anti-COVID-19 Vaccines: Pitfalls and Suggestions for Improvement.

Bellavite P, Donzelli A, Isidoro C J Clin Med. 2024; 13(23).

PMID: 39685749 PMC: 11642405. DOI: 10.3390/jcm13237291.


Biases in COVID-19 vaccine effectiveness studies using cohort design.

Agampodi S, Tadesse B, Sahastrabuddhe S, Excler J, Kim J Front Med (Lausanne). 2024; 11:1474045.

PMID: 39540039 PMC: 11557388. DOI: 10.3389/fmed.2024.1474045.

References
1.
Remschmidt C, Wichmann O, Harder T . Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect Dis. 2015; 15:429. PMC: 4609091. DOI: 10.1186/s12879-015-1154-y. View

2.
Ioannidis J . Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies. BMJ Evid Based Med. 2022; 27(6):324-329. PMC: 9691814. DOI: 10.1136/bmjebm-2021-111901. View

3.
Berrino F, Donzelli A, Bellavite P, Malatesta G . COVID-19 vaccination and all-cause and non-COVID-19 mortality. A revaluation of a study carried out in an Italian Province. Epidemiol Prev. 2024; 47(6):374-378. DOI: 10.19191/EP23.6.A643.075. View

4.
Jackson L, Jackson M, Nelson J, Neuzil K, Weiss N . Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2005; 35(2):337-44. DOI: 10.1093/ije/dyi274. View

5.
Furst T, Straka R, Janosek J . Healthy vaccinee effect: a bias not to be forgotten in observational studies on COVID-19 vaccine effectiveness. Pol Arch Intern Med. 2024; 134(2). DOI: 10.20452/pamw.16634. View